Conversely, MOTS-c inhibited the differentiation of CD4+ interferon gamma (IFNγ)+ T helper type 1 (Th1) cells, which have high glycolytic activity and are associated with the pathogenesis of T1D [87]. This evidence concerns the gene IFNG and type 1 diabetes mellitus.